金河生物：金河控股9月1日前减持3%

Summary of Key Points Core Viewpoint - The controlling shareholder, Jinhe Holdings, has reduced its stake in Jinhe Biological through block trading and centralized bidding, indicating a strategic shift in ownership structure [1] Group 1: Shareholding Changes - Jinhe Holdings reduced its stake by 15,042,100 shares through block trading at an average price of 6.81 CNY per share, accounting for 2.0000% of the total share capital after excluding repurchased shares [1] - Additionally, 7,521,000 shares were sold through centralized bidding at an average price of 7.26 CNY per share, representing 1.0000% of the total share capital [1] - The total reduction amounted to 22,563,100 shares, which is 3.0000% of the total share capital after excluding repurchased shares [1] Group 2: Remaining Shareholding - After the reduction, the controlling shareholder and its concerted parties hold a total of 256,000,000 shares, which constitutes 34.0615% of the total share capital after excluding repurchased shares [1]